Shaji Kumar Selected Research

vendex

1/2021

Targeting BCL-2 with venetoclax and dexamethasone in patients with relapsed/refractory t(11;14) multiple myeloma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shaji Kumar Research Topics

Disease

186	Multiple Myeloma 04/2024 - 12/2002
40	Neoplasms (Cancer) 11/2023 - 02/2002
33	Immunoglobulin Light-chain Amyloidosis 04/2024 - 08/2006
22	Amyloidosis 09/2023 - 03/2007
17	Disease Progression 10/2022 - 08/2004
13	Paraproteinemias (Monoclonal Gammopathy) 11/2022 - 02/2002
10	Hematologic Neoplasms (Hematological Malignancy) 11/2023 - 05/2008
9	Monoclonal Gammopathy of Undetermined Significance 11/2022 - 08/2004
7	POEMS Syndrome (Syndrome, POEMS) 12/2022 - 11/2008
7	Waldenstrom Macroglobulinemia (Macroglobulinemia) 01/2021 - 08/2008
6	Chromosome Aberrations (Chromosome Abnormalities) 09/2023 - 09/2015
6	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2022 - 04/2003
6	Smoldering Multiple Myeloma 10/2020 - 08/2004
6	Lymphoma (Lymphomas) 01/2018 - 04/2003
5	Exanthema (Rash) 10/2017 - 08/2008
4	Infections 09/2023 - 01/2020
4	Residual Neoplasm 01/2022 - 01/2019
4	Plasma Cell Leukemia 07/2021 - 12/2015
4	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2021 - 03/2012
4	Anemia 01/2019 - 05/2012
3	COVID-19 12/2023 - 01/2020
3	Neutropenia 09/2023 - 01/2019
3	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2022 - 10/2009
3	Fatigue 01/2022 - 01/2017
3	Frailty 01/2022 - 11/2016
3	Thrombocytopenia (Thrombopenia) 10/2017 - 04/2016
3	Peripheral Nervous System Diseases (PNS Diseases) 10/2017 - 01/2015
3	Renal Insufficiency (Renal Failure) 11/2014 - 06/2010
3	Proteinuria 10/2014 - 03/2012
3	Necrosis 12/2012 - 10/2003
2	Plasma Cell Neoplasms 10/2021 - 09/2013
2	Inflammation (Inflammations) 01/2021 - 06/2005
2	Bone Diseases (Bone Disease) 01/2019 - 08/2006
2	Glomerulonephritis 04/2018 - 05/2015
2	Plasmacytoma 01/2018 - 09/2008
2	Lymphadenopathy 01/2018 - 05/2012
2	Nausea 10/2017 - 01/2017
2	Leukemia 06/2015 - 11/2004

Drug/Important Bio-Agent (IBA)

41	Dexamethasone (Maxidex)FDA LinkGeneric 04/2024 - 07/2005
38	Lenalidomide (CC 5013)FDA Link 11/2023 - 12/2004
24	Bortezomib (Velcade)FDA Link 04/2024 - 04/2005
20	Proteins (Proteins, Gene)FDA Link 11/2022 - 08/2005
15	Proteasome InhibitorsIBA 12/2023 - 06/2008
14	Thalidomide (Thalomid)FDA Link 08/2011 - 01/2003
13	Cyclophosphamide (Cytoxan)FDA LinkGeneric 04/2024 - 01/2012
12	daratumumabIBA 04/2024 - 01/2019
11	Biomarkers (Surrogate Marker)IBA 05/2024 - 10/2007
11	ixazomibIBA 09/2022 - 01/2015
10	Immunoglobulin M (IgM)IBA 01/2020 - 08/2008
9	Immunoglobulins (Immunoglobulin)IBA 11/2022 - 11/2008
9	Immunomodulating AgentsIBA 01/2022 - 01/2005
7	Amyloid (Amyloid Fibrils)IBA 09/2023 - 08/2008
7	Melphalan (Alkeran)FDA LinkGeneric 01/2023 - 12/2006
7	Interleukin-6 (Interleukin 6)IBA 02/2009 - 10/2003
6	Immunoglobulin G (IgG)IBA 01/2022 - 06/2010
6	Monoclonal AntibodiesIBA 01/2022 - 08/2003
6	pomalidomideIBA 01/2022 - 10/2009
6	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2012 - 08/2004
5	Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA 11/2018 - 12/2012
5	CytokinesIBA 09/2013 - 08/2004
4	B-Cell Maturation AntigenIBA 03/2024 - 01/2022
4	carfilzomibIBA 01/2023 - 12/2019
4	Immunoglobulin A (IgA)IBA 01/2021 - 06/2010
4	Rituximab (Mabthera)FDA Link 08/2018 - 08/2008
4	CaspasesIBA 02/2014 - 09/2005
3	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 03/2024 - 01/2021
3	AntigensIBA 12/2023 - 04/2007
3	venetoclaxIBA 09/2023 - 11/2017
3	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 06/2008
3	AntibodiesIBA 01/2021 - 08/2005
3	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2019 - 03/2007
3	Sirolimus (Rapamycin)FDA Link 03/2012 - 12/2004
2	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2019
2	Chimeric Antigen ReceptorsIBA 01/2022 - 01/2020
2	Drug CombinationsIBA 01/2022 - 11/2014
2	Prednisone (Sone)FDA LinkGeneric 01/2022 - 06/2019
2	InterferonsIBA 01/2022 - 01/2021
2	Bevacizumab (Avastin)FDA Link 01/2022 - 01/2017
2	VaccinesIBA 06/2021 - 12/2009
2	antineoplaston A10 (A 10)IBA 01/2020 - 02/2010
2	OligonucleotidesIBA 01/2020 - 08/2007
2	Inosine Monophosphate (IMP)IBA 06/2019 - 09/2005
2	Aurora KinasesIBA 10/2018 - 01/2016
2	Sorafenib (BAY 43-9006)FDA Link 01/2017 - 03/2012
2	CreatinineIBA 01/2017 - 06/2013
2	pro-brain natriuretic peptide (1-76)IBA 11/2016 - 03/2012
2	Brain Natriuretic Peptide (Natrecor)FDA Link 11/2016 - 03/2012
2	Mechanistic Target of Rapamycin Complex 1IBA 11/2014 - 10/2009
2	Dihydrotachysterol (AT 10)IBA 10/2014 - 05/2012

Therapy/Procedure

96	Therapeutics 12/2023 - 12/2002
40	Stem Cell Transplantation 11/2023 - 10/2005
16	Drug Therapy (Chemotherapy) 03/2023 - 12/2002
16	Cell Transplantation 12/2022 - 08/2011
14	Transplantation 01/2023 - 03/2007
10	Autologous Transplantation 01/2022 - 12/2009
8	Hematopoietic Stem Cell Transplantation 11/2021 - 05/2003
5	Kidney Transplantation 04/2022 - 06/2011
2	Immunotherapy 04/2024 - 01/2021
2	Induction Chemotherapy 01/2021 - 01/2019
2	Aftercare (After-Treatment) 01/2021 - 08/2008